Skip to main content
. 2015 Jan 7;211(12):1969–1976. doi: 10.1093/infdis/jiu841

Table 1.

Demographic Characteristics of Study Subjects

Characteristic Group 1, 40% ID (n = 66) Group 2, 20% ID (n = 66) Group 3, 100% IM (n = 66) Group 4, 40% IM (n = 33) P Value
Age, y
 Mean ± SD 45 ± 10 45 ± 11 46 ± 11 46 ± 11 .96
 Range 24–61 23–70 21–63 21–63
Female sex 36 (24) 36 (24) 32 (21) 21 (7) .42
Race .68
 White 29 (19) 26 (17) 29 (19) 33 (11)
 Black 71 (47) 73 (48) 71 (47) 64 (21)
 Other 0 (0) 2 (1) 0 (0) 3 (1)
Born in the US 98 (65) 95 (63) 91 (60) 94 (31) .38
Lived or traveled internationally 27 (18) 29 (19) 44 (29) 36 (12) .16
Received all childhood vaccines 97 (64) 97 (64) 91 (60) 94 (31) .43
Year of HIV infection diagnosis, meana 2001 2002 2001 2001 .90
Currently receiving ART 97 (64) 97 (64) 100 (66) 100 (33) .90
CD4+ T-cell count in cells/mm3, mean ± SD
 Most recent 669 ± 361 630 ± 331 676 ± 354 569 ± 260 .44
 Lowest in the medical record 328 ± 269 287 ± 221 294 ± 294 322 ± 260 .8
Most recent HIV load (copies/mL), mean ± SD 111 ± 95 82 ± 86 85 ± 78 99 ± 69 .67
Diagnosis of AIDS in the record 58 (38) 50 (33) 59 (39) 52 (17) .69
Ever homeless 39 (26) 33 (22) 21 (14) 21 (7) .08
Current smoker 58 (38) 47 (31) 35 (23) 39 (13) .06
Coinfected with hepatitis C virus 18 (12) 15 (10) 9 (6) 15 (5) .48
Coinfected with hepatitis B virus 11 (7) 6 (4) 3 (2) 0 (0) .29
History of hypertension 42 (28) 38 (25) 42 (28) 45 (15) .89
History of depression or bipolar disorder 33 (22) 33 (22) 29 (19) 27 (9) .87
IPV lot no. received .92
 H1452–1 9 (6) 9 (6) 14 (9) 12 (4)
 H1604–1 29 (19) 26 (17) 21 (14) 21 (7)
 H1605–2 62 (41) 65 (43) 65 (43) 67 (22)

Data are % (no.) of subjects, unless otherwise indicated.

Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; ID, intradermal; IM, intramuscular; IPV, inactivated polio vaccine; SD, standard deviation.

a The SD for groups 1–3 was 8 years, and the SD for group 4 was 9 years.